Altimmune Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
14.86
0.29
(1.99%)
Volume:
272,854
52 week range:
7.8 - 24.61
Market Cap:
590.029M
Company Description:
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).